3 results
6-K
EX-99.3
OBSVF
ObsEva SA
28 Jan 22
ObsEva Announces Corporate Updates
5:16pm
is an “Acquiring Person” under any control share acquisition, business combination, poison pill (including any distribution under a rights agreement) or similar
6-K/A
EX-99.2
OBSVF
ObsEva SA
13 Oct 21
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
5:24pm
acquisition, business combination, poison pill (including any distribution under a rights agreement) or similar anti-takeover plan or arrangement in effect
6-K
EX-99.2
OBSVF
ObsEva SA
13 Oct 21
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
9:27am
any control share acquisition, business combination, poison pill (including any distribution under a rights agreement) or similar anti-takeover plan
- Prev
- 1
- Next